BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8967952)

  • 1. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.
    Huang B; Eberstadt M; Olejniczak ET; Meadows RP; Fesik SW
    Nature; 1996 Dec 19-26; 384(6610):638-41. PubMed ID: 8967952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain.
    Eberstadt M; Huang B; Chen Z; Meadows RP; Ng SC; Zheng L; Lenardo MJ; Fesik SW
    Nature; 1998 Apr; 392(6679):941-5. PubMed ID: 9582077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-dimensional solution structure and dynamic properties of the human FADD death domain.
    Berglund H; Olerenshaw D; Sankar A; Federwisch M; McDonald NQ; Driscoll PC
    J Mol Biol; 2000 Sep; 302(1):171-88. PubMed ID: 10964568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.
    Okura T; Gong L; Kamitani T; Wada T; Okura I; Wei CF; Chang HM; Yeh ET
    J Immunol; 1996 Nov; 157(10):4277-81. PubMed ID: 8906799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1.
    Telliez JB; Xu GY; Woronicz JD; Hsu S; Wu JL; Lin L; Sukits SF; Powers R; Lin LL
    J Mol Biol; 2000 Jul; 300(5):1323-33. PubMed ID: 10903872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A death-domain-containing receptor that mediates apoptosis.
    Kitson J; Raven T; Jiang YP; Goeddel DV; Giles KM; Pun KT; Grinham CJ; Brown R; Farrow SN
    Nature; 1996 Nov; 384(6607):372-5. PubMed ID: 8934525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
    Bajorath J
    Proteins; 1999 Jun; 35(4):475-82. PubMed ID: 10382675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
    Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW
    Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
    Starling GC; Kiener PA; Aruffo A; Bajorath J
    Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structure of the death domain of the p75 neurotrophin receptor.
    Liepinsh E; Ilag LL; Otting G; Ibáñez CF
    EMBO J; 1997 Aug; 16(16):4999-5005. PubMed ID: 9305641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the tumor necrosis factor receptor-1 death domain.
    Sukits SF; Lin LL; Hsu S; Malakian K; Powers R; Xu GY
    J Mol Biol; 2001 Jul; 310(4):895-906. PubMed ID: 11453696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1.
    Day CL; Dupont C; Lackmann M; Vaux DL; Hinds MG
    Cell Death Differ; 1999 Nov; 6(11):1125-32. PubMed ID: 10578182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J; Esteban M
    Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.
    Langedijk JP; de Groot BL; Berendsen HJ; van Oirschot JT
    Virology; 1998 Apr; 243(2):293-302. PubMed ID: 9568029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.
    Condorelli G; Vigliotta G; Cafieri A; Trencia A; Andalò P; Oriente F; Miele C; Caruso M; Formisano P; Beguinot F
    Oncogene; 1999 Aug; 18(31):4409-15. PubMed ID: 10442631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the tumor necrosis factor receptor superfamily.
    Bajorath J
    J Mol Graph Model; 1999; 17(3-4):220-2. PubMed ID: 10736780
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural basis for self-association and receptor recognition of human TRAF2.
    Park YC; Burkitt V; Villa AR; Tong L; Wu H
    Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.